Work

Repeated intravenous thrombolysis in early recurrent stroke secondary to carotid web: Case report

Year: 2021

Type: article

Abstract: Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) is the first effective approved treatment for reducing ischemic stroke disability, and having a stroke within 3 months is usually a contraindication to thrombolysis. In this paper, we describe the case of a 58-year-old patient who received repeated intravenous thrombolysis at 10 days interval for a recurrent ischemic stroke, with dramatic improvement. The carotid diaphragm was behind this recurrent stroke and it was treated by stenting.

Source: Radiology Case Reports

DOI: 10.1016/j.radcr.2021.01.026

Authors: Siham Bouchal, Youssef Alaoui Lamrani, Naima Chtaou, Mustafa Maaroufi, Faouzi Belahsen

Institutions: Centre Hospitalier Universitaire Hassan II, Sidi Mohamed Ben Abdellah University

Language: English

Topic: Acute Ischemic Stroke Management

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $500